DNAtrix’s Oncolytic Immunotherapy, DNX-2401, Awarded EU Orphan Medicine Designation for Treating Malignant Brain Tumors Read more
Oracle Powers Precision Medicine Delivery with New Solution Connecting Research, Pathology and Clinical Care Read more
Boehringer Ingelheim Selects Medidata Clinical Cloud to Accelerate Innovation in Drug Development Read more
XL-protein & Easton sign license agreement to develop biopharmaceuticals using PASylation technology Read more